Molina Healthcare, Inc. (MOH)
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates through Medicaid, Medicare, Marketplace, and Other segments. The company was founded in 1980 and is headquartered in Long Beach, California.
- Symbol
- MOH
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Market cap
- $9.86B
- 52 week range
- 121.06 - 244.89
Valuation
- Share price
- $189.54 (close of 2026-10-02)
- P/E (TTM)
- 1114.94x
- Price to book
- 2.36x
- Price to free cash flow
- 36.37x
- Enterprise value
- $8.82B
- Book value per share
- $80.21
Price performance
| Period | Change |
|---|---|
| 1 day | +4.81% |
| 5 days | -0.69% |
| 1 month | -6.46% |
| 3 months | -17.54% |
| 6 months | +35.99% |
| Year to date | +9.22% |
| 1 year | -2.42% |
| 3 years | -42.99% |
| 5 years | -30.19% |
| 10 years | +225.00% |
| All time | +1321.91% |
Members of Congress who disclosed MOH trades
Gilbert Ray Cisneros · Byron Donalds · Robert Bresnahan
Super investors holding MOH
Bill Nygren (Harris Associates LP) · Seth Klarman (Baupost Group) · Michael Burry (Scion Asset Mgmt) · Ken Griffin (Citadel) · Ray Dalio (Bridgewater Associates)
Profitability and growth
- Return on equity
- 11.60%
- Return on invested capital
- 17.61%
- Return on assets
- 3.03%
- Return on capital employed
- 9.53%
- Gross margin
- 13.07%
- Net margin
- 1.04%
- EBITDA margin
- 2.15%
- Revenue growth
- 11.75%
- Net income growth
- -59.97%
- Free cash flow growth
- -216.91%
Cash flow and balance sheet
- Free cash flow yield (TTM)
- 2.75%
- Current ratio
- 1.68x
- Net debt to EBITDA
- -2.78x
Latest reported year
- Period end
- 2025-12-31
- Fiscal year
- 2025
- Revenue
- $45.43B
- Cost of revenue
- $39.49B
- Gross profit
- $5.94B
- EBITDA
- $976.00M
- Net income
- $472.00M
- Earnings per share
- $8.93
- Shares outstanding
- 52.80M
Income statement by year
| Period end | Revenue | Gross profit | Net income | EPS |
|---|---|---|---|---|
| 2025-12-31 | $45.43B | $5.94B | $472.00M | $8.93 |
| 2024-12-31 | $40.65B | $6.22B | $1.18B | $20.52 |
| 2023-12-31 | $34.07B | $5.40B | $1.09B | $18.91 |
| 2022-12-31 | $31.97B | $4.80B | $792.00M | $13.72 |
| 2021-12-31 | $27.77B | $4.07B | $659.00M | $11.40 |
| 2020-12-31 | $19.42B | $2.48B | $673.00M | $11.40 |
| 2019-12-31 | $16.83B | $2.30B | $737.00M | $11.85 |
| 2018-12-31 | $18.89B | $2.52B | $707.00M | $11.57 |
| 2017-12-31 | $19.88B | $1.81B | -$512.00M | $-9.07 |
| 2016-12-31 | $17.78B | $1.73B | $52.00M | $0.93 |
Margins and returns by year
| Period end | Gross margin | Net margin | Return on equity | Return on capital |
|---|---|---|---|---|
| 2025-12-31 | 13.07% | 1.04% | 11.60% | 17.61% |
| 2024-12-31 | 15.31% | 2.90% | 26.22% | 43.94% |
| 2023-12-31 | 15.86% | 3.20% | 25.88% | 68.49% |
| 2022-12-31 | 15.01% | 2.48% | 26.72% | 66.86% |
| 2021-12-31 | 14.64% | 2.37% | 25.06% | 109.69% |
| 2020-12-31 | 12.76% | 3.46% | 32.11% | 214.09% |
| 2019-12-31 | 13.68% | 4.38% | 37.60% | 75.26% |
| 2018-12-31 | 13.33% | 3.74% | 42.93% | - |
| 2017-12-31 | 9.10% | -2.58% | -38.29% | - |
| 2016-12-31 | 9.70% | 0.29% | 3.15% | 55.23% |
Cash and debt by year
| Period end | Cash | Debt |
|---|---|---|
| 2025-12-31 | $4.25B | $3.77B |
| 2024-12-31 | $4.66B | $2.92B |
| 2023-12-31 | $4.85B | $2.18B |
| 2022-12-31 | $4.01B | $2.18B |
| 2021-12-31 | $4.44B | $2.17B |
| 2020-12-31 | $4.15B | $2.13B |
| 2019-12-31 | $2.45B | $1.24B |
| 2018-12-31 | $2.83B | $1.02B |
| 2017-12-31 | $3.19B | $1.32B |
| 2016-12-31 | $2.82B | $975.00M |
Free cash flow by year
| Period end | Free cash flow | Stock-based compensation |
|---|---|---|
| 2025-12-31 | -$636.00M | $47.00M |
| 2024-12-31 | $544.00M | $116.00M |
| 2023-12-31 | $1.58B | $115.00M |
| 2022-12-31 | $682.00M | $103.00M |
| 2021-12-31 | $2.04B | $72.00M |
| 2020-12-31 | $1.82B | $57.00M |
| 2019-12-31 | $377.00M | $39.00M |
| 2018-12-31 | -$344.00M | $27.00M |
| 2017-12-31 | $718.00M | $46.00M |
| 2016-12-31 | $497.00M | $26.00M |
Investor relations
Next earnings report
- Next confirmed report
- 2026-10-21
- Consensus EPS estimate
- $0.73
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|---|---|
| 2026-07-22 | Jun/2026 | $1.37 |
| 2026-04-22 | Mar/2026 | $1.57 |
| 2026-02-05 | Dec/2025 | $0.43 |
| 2025-10-22 | Sep/2025 | $3.97 |
| 2025-07-23 | Jun/2025 | $5.50 |
| 2025-04-23 | Mar/2025 | $5.86 |
| 2025-02-05 | Dec/2024 | $5.81 |
| 2024-10-23 | Sep/2024 | $5.96 |
Filings and sources
- Company website
- molinahealthcare.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
Centene Corp (CNC) · Humana Inc (HUM) · Cigna Group (CI) · Elevance Health, Inc. (ELV) · HCA Healthcare, Inc. (HCA) · DaVita Inc. (DVA) · Universal Health Services Inc (UHS) · Abbott Laboratories (ABT)
Understanding these figures
Price-to-earnings ratio · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades